KISQALI
Active substance: ribociclib
TABLET, FILM COATED · RIBOCICLIB SUCCINATE 200 mg/1
United StatesActive
Marketing holder: Novartis Pharmaceuticals Corporation
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- RIBOCICLIB SUCCINATE · 200 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-fa83-7c19-b808-0465b46915cf,01a1208c-fa89-7c20-aecd-3d20fead3591,01a1208e-0331-79e6-bd75-b849d1f5ce2a;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0078-0874
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0078-0874 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0078-0874 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0078-0874 · Verified 2026-10-09 · open in source